Organ-specific accuracy of [ 18 F]FDG-PET/CT in identifying immune-related adverse events in patients with high-risk melanoma treated with adjuvant immune checkpoint inhibitor.
Birte Molvik GideonseMagnus BirkelandMie Holm VilstrupPeter GrupeMohammad Naghavi-BehzadChristina H RuhlmannOke GerkeMalene Grubbe HildebrandtPublished in: Japanese journal of radiology (2024)
F]FDG-PET/CT generally had moderate to high sensitivities (except for skin and heart) and specificities in diagnosing irAEs in patients receiving adjuvant ICI; this could be suggested to be systematically assessed and reported in scan reports.